Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study
Mina C. Hosseinipour, Sam Phiri(Lighthouse Trust), Salem Gugsa(Office of the National Coordinator for Health Information Technology), Kara Compliment(University of North Carolina at Chapel Hill), Florence Kasende(Dignitas International), Sarah E. Rutstein(University of North Carolina at Chapel Hill), Frank Chimbwandira(Centers for Disease Control and Prevention), Erik J Schouten(Public Health Institute of Malawi), Clement Trapence(Lighthouse Trust), Levison Chiwaula(University of Malawi), Blessings N. Kaunda-Khangamwa(University of Malawi), Fabian Cataldo(Dignitas International), Monique van Lettow(University of Toronto), Hannock Tweya(International Union Against Tuberculosis and Lung Disease), Virginia Kayoyo, Atupele Kapito–Tembo(University of Malawi), Veena Sampathkumar(Christian Health Association of Malawi), Julie A. Nelson(University of North Carolina at Chapel Hill), Nora E. Rosenberg, Christopher Stanley, Michael Eliya(Ministry of Health)
Cited by 55
Related Papers
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
|The Lancet HIV|2016|177